Paul Michael Bunch

Dr. Paul Michael Bunch

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Closed access
PDF file
PBPaul Michael Bunch
Paul Michael Bunch
HKHillary R. Kelly
Hillary R. Kelly
Importance Successful minimally invasive parathyroidectomy requires confident and accurate preoperative localization. Several noninvasive imaging techniques are well established for preoperative localization, and others are emerging. Observations Ultrasonography and sestamibi imaging are established preoperative localization techniques with good sensitivity and positive predictive value. Multiphase 4-dimensional computed tomography is a newer technique with arguably superior performance, particularly in the setting of negative or discordant ultrasonography and sestamibi imaging, residual or recurrent primary hyperparathyroidism following a previous surgical operation, and multiglandular disease. Emerging techniques that may further facilitate confident and accurate preoperative localization include ultrasonography, elastography, positron emission tomography, and 4-D magnetic resonance imaging. Conclusions and Relevance The optimal imaging localization algorithm for hyperparathyroidism remains undetermined, but a combination of techniques tailored to the specific scenario will likely yield the best outcomes. An algorithm is proposed that considers test performance, surgeon confidence, patient-specific factors, cost, local radiologic expertise, and patient radiation exposure.

1 September 2020 in RadioGraphics
Verified
Journal Article
Closed access
PBPaul Michael Bunch
Paul Michael Bunch
GRGregory W. Randolph
Gregory W. Randolph
JBJennifer A. Brooks
Jennifer A. Brooks
VGValerie George
Valerie George
JCJennifer Cannon
Jennifer Cannon
HKHillary R. Kelly
Hillary R. Kelly
By understanding the relevant anatomy, embryology, and operative considerations and by accurately reporting and addressing the key information the surgeon desires from parathyroid four-dimensional ... Parathyroid four-dimensional (4D) CT is an increasingly used and powerful tool for preoperative localization of abnormal parathyroid tissue in the setting of primary hyperparathyroidism. Accurate a...

1 October 2016 in American Journal of Roentgenology
Verified
Journal Article
Closed access
JWJeremy R. Wortman
Jeremy R. Wortman
PBPaul Michael Bunch
Paul Michael Bunch
UFUrvi P. Fulwadhva
Urvi P. Fulwadhva
GBGregory A. Bonci
Gregory A. Bonci
ASAaron D. Sodickson
Aaron D. Sodickson
OBJECTIVE. The purpose of this article is to review the added value of dual-energy CT for characterization of incidental lesions discovered during routine abdominal CT. CONCLUSION. Dual-energy CT allows acquisition of virtual unenhanced images, iodine maps, and virtual monochromatic images, all of which can aid in characterizing incidental lesions at the time of detection. Virtual unenhanced images and iodine maps are used for assessment of enhancement of incidental lesions, which can help differentiate suspicious enhancing lesions from benign nonenhancing lesions. Virtual monochromatic images can be obtained at low energy to improve conspicuity and detection of subtle lesions. Routine use of dual-energy CT may eliminate the need for additional imaging in the workup of some of these incidental lesions.

1 July 2018 in Radiology
Verified
Journal Article
Closed access
PSPaul B. Shyn
Paul B. Shyn
LCLeigh C. Casadaban
Leigh C. Casadaban
NSNisha I. Sainani
Nisha I. Sainani
CSCheryl A. Sadow
Cheryl A. Sadow
PBPaul Michael Bunch
Paul Michael Bunch
SSStuart G. Silverman
Stuart G. Silverman
Intraprocedural depiction of both the ablated liver tumor and entire ablation margin is feasible by using nitrogen 13 ammonia perfusion PET during FDG PET/CT-guided microwave ablation. Purpose To prospectively determine whether nitrogen 13 (13N) ammonia perfusion positron emission tomography (PET) during fluorine 18 fluorodeoxyglucose (FDG) PET/computed tomography (CT)–guided liver tumor ablation can be used to intraprocedurally assess ablation margins. Materials and Methods Eight patients (five women and three men; age range, 36–74 years; mean age, 57 years) were enrolled in this pilot study and underwent FDG PET/CT–guided microwave ablation of 11 FDG-avid liver metastases (mean diameter, 22 mm; range, 11–34 mm). All procedures were performed between March 2014 and December 2016. Complete ablation margin visibility and minimum ablation margin thickness were assessed by using intraprocedural 13N-ammonia perfusion PET compared with 24-hour postprocedural MR imaging by two independent blinded radiologists. Local tumor progression for each ablated tumor was assessed at follow-up imaging for 3–38 months (median, 17.6 months). Descriptive analysis was performed. Results Eleven of 11 (100%) a...

25 March 2017 in Skeletal Radiology
Verified
Journal Article
Open access
PDF file
PBPaul Michael Bunch
Paul Michael Bunch
TATalissa A. Altes
Talissa A. Altes
JMJoan McIlhenny
Joan McIlhenny
JPJames Patrie
James Patrie
CGCree M. Gaskin
Cree M. Gaskin
To assess reader performance and subjective workflow experience when reporting bone age studies with a digital bone age reference as compared to the Greulich and Pyle atlas (G&P). We hypothesized that pediatric radiologists would achieve equivalent results with each method while digital workflow would improve speed, experience, and reporting quality.

16 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
KBKimberly Burcher
Kimberly Burcher
JLJeffrey Lantz
Jeffrey Lantz
EGElena Gavrila
Elena Gavrila
AAArianne Abreu
Arianne Abreu
Jack Thomas BurcherJack Thomas Burcher
Jack Thomas Burcher
MPMercedes Porosnicu
Mercedes Porosnicu
Failure to predict response to immunotherapy (IO) limited its benefit in the treatment of head and neck squamous cell cancer (HNSCC) to 20% of patients or less. Biomarkers including tumor mutational burden (TMB) and programmed death ligand-1 (PD-L1) were evaluated as predictors of response to IO, but the results are inconsistent and with a lack of standardization of their methods. In this retrospective study, TMB and PD-L1 were measured by commercially available methodologies and were correlated to demographics, outcome, and response to PD-1 inhibitors. No correlation was found between TMB and PD-L1 levels. High TMB was associated with smoking and laryngeal primaries. PD-L1 was significantly higher in African Americans, patients with earlier stage tumors, nonsmokers, and nonethanol drinkers. Patients with high TMB fared better in univariate and multivariate survival analysis. No correlation was found between PD-L1 expression and prognosis. There was a statistically significant association between PFS and response to IO and TMB. There was no association between response to ICI and PD-L1 in this study, possibly affected by variations in the reporting method. Further studies are needed to characterize the biomarkers for IO in HNSCC, and this study supports further research into the advancement of TMB in prospective studies.